EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan



The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan



European Journal of Immunology 4(5): 370-377




(PDF emailed within 0-6 h: $19.90)

Accession: 044655585

Download citation: RISBibTeXText

PMID: 4153121

DOI: 10.1002/eji.1830040513



Related references

The immunological properties of haptens coupled to thymus independent carrier molecules part 1 the characteristics of the immune response to di nitro phenyl lysine substituted pneumococcal poly saccharide s iii and levan. European Journal of Immunology 4(5): 370-377, 1974

The immunological properties of haptens coupled to thymus-independent carrier molecules. IV. The IgG response to dinitrophenylated Ficoll. European Journal of Immunology 6(6): 429-433, 1976

The immunological properties of haptens coupled to thymus independent carrier molecules part 4 the immuno globulin g response to di nitro phenylated ficoll. European Journal of Immunology 6(6): 429-433, 1976

The immunological properties of haptens coupled to thymus-independent carrier molecules. III. The role of the immunogenicity and mitogenicity of the carrier in the induction of primary IgM anti-hapten responses. European Journal of Immunology 5(2): 105-111, 1975

The immunological properties of haptens coupled to thymus independent carrier molecules part 3 the role of the immunogenicity and mitogenicity of the carrier in the induction of primary immuno globulin m anti hapten responses. European Journal of Immunology 5(2): 105-111, 1975

The immunological properties of haptens coupled to thymus-independent carrier molecules. II. The influence of the graft-versus-host reaction on primary antibody responses to hapten-coupled polysaccharides and proteins. European Journal of Immunology 4(7): 505-511, 1974

The immunological properties of haptens coupled to thymus independent carrier molecules part 2 the influence of the graft vs host reaction on primary antibody responses to hapten coupled poly saccharides and proteins. European Journal of Immunology 4(7): 505-511, 1974

The immune response in mice to the haptenic determinant DNP coupled to a thymus-independent carrier (levan). Journal of Immunology 109(5): 951-956, 1972

The immune response in mice to the haptenic determinant di nitro phenol coupled to a thymus independent carrier levan. Journal Of Immunology: 951-956, 1972

The immune response against two epitopes on the same thymus-independent polysaccharide carrier. II. Enhanced anti-hapten responses by injection of the unconjugated carrier. Immunology 33(3): 331-337, 1977

Immune response against two epitopes on the same thymus-independent polysaccharide carrier. 1. Role of epitope density in carrier-dependent immunity and tolerance. Immunology 33(1): 59-68, 1977

The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. Journal of Immunology 116(2): 469-474, 1976

In vivo immune response to TNP hapten coupled to thymus-independent carrier lipopolysaccharide. Cellular Immunology 16(2): 223-236, 1975

In vivo immune response to tri nitro phenol hapten coupled to thymus independent carrier lipo poly saccharide. Cellular Immunology 16(2): 223-236, 1975

The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice. Australian Journal of Experimental Biology and Medical Science 64: 19-35, 1986